FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225790790> ?p ?o ?g. }

• W4225790790 endingPage "270" @default.
• W4225790790 startingPage "261" @default.
• W4225790790 abstract "Though second-generation antihistamines (SGAH) are first-line drugs in chronic spontaneous urticaria (CSU), 50% of patients do not respond to them. In such patients, guidelines recommend either up-dosing of SGAH or combination of different antihistamines. However, the studies comparing these treatment regimens are limited.In this comparative, three-arm study, CSU patients were randomized to receive standard dose of either bilastine, fexofenadine, or levocetirizine for 2 weeks. After 2 weeks of treatment, non-responders received double dose of either bilastine or fexofenadine, while hydroxyzine 25 mg once daily was added in the levocetirizine group. Patients were primarily evaluated for improvement in CSU, quality of life, and somnolence.A total of 110 patients with CSU were recruited. At the end of 4 weeks, 33/39, 26/35, and 22/36 patients in the bilastine, fexofenadine, and levocetirizine groups showed improvement in urticaria symptoms. At week 2, there was no statistical difference in urticaria activity score (UAS7) improvement between any of the groups; however, at week 4, there was a statistical difference between the bilastine and levocetirizine groups (p<0.05). Somnolence was significantly lower in the bilastine group (p<0.05). Bilastine was statistically significant (p<0.05) in the improvement of quality of life as compared to both groups. No major adverse events were reported during study period; however, bilastine was associated with significantly lower levels of AEs compared to levocetirizine (p<0.05).Two-fold up-dosing of bilastine improves CSU symptoms without compromising safety as compared to two-fold up-dosing of fexofenadine and combination of first- and second-generation antihistamines." @default.
• W4225790790 created "2022-05-05" @default.
• W4225790790 creator A5022394926 @default.
• W4225790790 creator A5032330467 @default.
• W4225790790 creator A5041889759 @default.
• W4225790790 creator A5051710377 @default.
• W4225790790 creator A5061916902 @default.
• W4225790790 creator A5069436933 @default.
• W4225790790 creator A5070489582 @default.
• W4225790790 creator A5089535952 @default.
• W4225790790 date "2022-02-01" @default.
• W4225790790 modified "2023-09-25" @default.
• W4225790790 title "A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria" @default.
• W4225790790 cites W120424435 @default.
• W4225790790 cites W1694898647 @default.
• W4225790790 cites W1773647412 @default.
• W4225790790 cites W1938809309 @default.
• W4225790790 cites W1970192162 @default.
• W4225790790 cites W1970635530 @default.
• W4225790790 cites W1982067695 @default.
• W4225790790 cites W1992491010 @default.
• W4225790790 cites W1994726262 @default.
• W4225790790 cites W1999304975 @default.
• W4225790790 cites W2002479630 @default.
• W4225790790 cites W2004083796 @default.
• W4225790790 cites W2007585390 @default.
• W4225790790 cites W2023246062 @default.
• W4225790790 cites W2029007329 @default.
• W4225790790 cites W2031640798 @default.
• W4225790790 cites W2036051127 @default.
• W4225790790 cites W2047558967 @default.
• W4225790790 cites W2052984212 @default.
• W4225790790 cites W2069724741 @default.
• W4225790790 cites W2081742934 @default.
• W4225790790 cites W2083240871 @default.
• W4225790790 cites W2105700711 @default.
• W4225790790 cites W2108667284 @default.
• W4225790790 cites W2124616677 @default.
• W4225790790 cites W2126299285 @default.
• W4225790790 cites W2126799517 @default.
• W4225790790 cites W2132229178 @default.
• W4225790790 cites W2140399799 @default.
• W4225790790 cites W2147420993 @default.
• W4225790790 cites W2149161476 @default.
• W4225790790 cites W2149389632 @default.
• W4225790790 cites W2186268229 @default.
• W4225790790 cites W2553796249 @default.
• W4225790790 cites W2588215277 @default.
• W4225790790 cites W2791703900 @default.
• W4225790790 cites W2807186297 @default.
• W4225790790 cites W2810953097 @default.
• W4225790790 cites W2918564088 @default.
• W4225790790 cites W2974659584 @default.
• W4225790790 cites W2984809349 @default.
• W4225790790 cites W3038595418 @default.
• W4225790790 cites W3087522660 @default.
• W4225790790 cites W3098371510 @default.
• W4225790790 cites W4210949141 @default.
• W4225790790 cites W4231566365 @default.
• W4225790790 cites W4241821473 @default.
• W4225790790 cites W4242194017 @default.
• W4225790790 cites W4243268282 @default.
• W4225790790 cites W4246780690 @default.
• W4225790790 cites W565535898 @default.
• W4225790790 doi "https://doi.org/10.2147/ccid.s350122" @default.
• W4225790790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35221703" @default.
• W4225790790 hasPublicationYear "2022" @default.
• W4225790790 type Work @default.
• W4225790790 citedByCount "2" @default.
• W4225790790 countsByYear W42257907902023 @default.
• W4225790790 crossrefType "journal-article" @default.
• W4225790790 hasAuthorship W4225790790A5022394926 @default.
• W4225790790 hasAuthorship W4225790790A5032330467 @default.
• W4225790790 hasAuthorship W4225790790A5041889759 @default.
• W4225790790 hasAuthorship W4225790790A5051710377 @default.
• W4225790790 hasAuthorship W4225790790A5061916902 @default.
• W4225790790 hasAuthorship W4225790790A5069436933 @default.
• W4225790790 hasAuthorship W4225790790A5070489582 @default.
• W4225790790 hasAuthorship W4225790790A5089535952 @default.
• W4225790790 hasBestOaLocation W42257907901 @default.
• W4225790790 hasConcept C126322002 @default.
• W4225790790 hasConcept C168563851 @default.
• W4225790790 hasConcept C197934379 @default.
• W4225790790 hasConcept C2776711289 @default.
• W4225790790 hasConcept C2777288759 @default.
• W4225790790 hasConcept C2778375690 @default.
• W4225790790 hasConcept C2779034229 @default.
• W4225790790 hasConcept C2779463773 @default.
• W4225790790 hasConcept C2780920841 @default.
• W4225790790 hasConcept C42219234 @default.
• W4225790790 hasConcept C71924100 @default.
• W4225790790 hasConcept C98274493 @default.
• W4225790790 hasConceptScore W4225790790C126322002 @default.
• W4225790790 hasConceptScore W4225790790C168563851 @default.
• W4225790790 hasConceptScore W4225790790C197934379 @default.
• W4225790790 hasConceptScore W4225790790C2776711289 @default.
• W4225790790 hasConceptScore W4225790790C2777288759 @default.
• W4225790790 hasConceptScore W4225790790C2778375690 @default.

• next